EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes

Dimitra Mavroeidi, Anastasia Georganta, Emmanouil Panagiotou iD, Konstantinos Syrigos, Vassilis L Souliotis iD

International Journal of Molecular Sciences · 27.02.2024 · 25 (5) · 2767

DOI: 10.3390/ijms25052767 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.02.2024. Verfasst von Dimitra Mavroeidi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece. Hauptthemen laut MEDLINE: DNA Repair, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The DNA damage response (DDR) system is a complicated network of signaling pathways that detects and repairs DNA damage or induces apoptosis. Critical regulators of the DDR network include the DNA damage kinases ataxia telangiectasia mutated Rad3-related kinase (ATR) and ataxia-telangiectasia mutated (ATM). The ATR pathway coordinates processes such as replication stress response, stabilization of replication forks, cell cycle arrest, and DNA repair. ATR inhibition disrupts these functions, causing a reduction of DNA repair, accumulation of DNA damage, replication fork collapse, inappropriate mitotic entry, and mitotic catastrophe. Recent data have shown that the inhibition of ATR can lead to synthetic lethality in ATM-deficient malignancies. In addition, ATR inhibition plays a significant role in the activation of the immune system by increasing the tumor mutational burden and neoantigen load as well as by triggering the accumulation of cytosolic DNA and subsequently inducing the cGAS-STING pathway and the type I IFN response. Taken together, we review stimulating data showing that ATR kinase inhibition can alter the DDR network, the immune system, and their interplay and, therefore, potentially provide a novel strategy to improve the efficacy of antitumor therapy, using ATR inhibitors as monotherapy or in combination with genotoxic drugs and/or immunomodulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairNeoplasmsHumansAtaxia Telangiectasia Mutated ProteinsDNA DamageTreatment Outcome

Stichwörter der Autor:innen

ATRATR inhibitorATR-ATM interplayDNA damage responseceralasertib (AZD6738)immune systemsynthetic lethality

Substanzen

Ataxia Telangiectasia Mutated ProteinsATR protein, human

Autor:innen und Institutionen

  • Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece.
  • Third Department of Medicine, Sotiria General Hospital for Chest Diseases, National and Kapodistrian University of Athens, 115 27 Athens, Greece.

ORCID-Profile: Emmanouil Panagiotou, Vassilis L Souliotis

Zitieren

APA

Mavroeidi, D., Georganta, A., Panagiotou, E., Syrigos, K., & Souliotis, V. L. (2024). Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes. International Journal of Molecular Sciences, 25(5), 2767. https://doi.org/10.3390/ijms25052767

Vancouver

Mavroeidi D, Georganta A, Panagiotou E, Syrigos K, Souliotis VL. Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes. International Journal of Molecular Sciences. 2024;25(5):2767. doi:10.3390/ijms25052767

BibTeX
@article{Mavroeidi2024,
  author = {Mavroeidi, Dimitra and Georganta, Anastasia and Panagiotou, Emmanouil and Syrigos, Konstantinos and Souliotis, Vassilis L},
  title = {Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {2767},
  doi = {10.3390/ijms25052767}
}
Kostenlos starten →